New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun(China Pharmaceutical University), Haopeng Sun(China Pharmaceutical University), Huanchao Guo(China Pharmaceutical University), Chrisanta Hamis Harakandi(China Pharmaceutical University), Lei Wang(China Pharmaceutical University), Chen Yao(Bristol-Myers Squibb (Germany)), Tengfei Zhen(China Pharmaceutical University)
Cited by 48
Related Papers
Palladium-Catalyzed <i>Meta</i>-Selective C–H Bond Activation with a Nitrile-Containing Template: Computational Study on Mechanism and Origins of Selectivity
|Journal of the American Chemical Society|2013|357
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Role of <i>N</i>-Acyl Amino Acid Ligands in Pd(II)-Catalyzed Remote C–H Activation of Tethered Arenes
|Journal of the American Chemical Society|2013|289
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270